CSNK1A1 and osteosarcoma: Given that ubiquitin-mediated proteolysis of CBX4 is dependent on its T437 phosphorylation by CK1α, and that CBX4 promotes osteosarcoma cell migration and invasion, drugs that potentiate CK1α kinase activity should be beneficial to osteosarcoma patients with metastasis.